Select Page
Responsive Centered YouTube Video
Discussion on potential long-term health risks of spike protein from COVID-19 research
  • Researchers focused on spike protein effects and entry mechanisms 0:00

  • Collaboration with global groups to combat COVID-19 since early pandemic 1:50

  • Focus on understanding damages and mitigation strategies 3:11

  • Research group leader from Pakistan with expertise in infectious diseases 3:53

  • Importance of spike protein in viral entry and vaccine mechanisms 4:36

  • Investigation into blocking viral entry and replication processes 5:40

  • Study of mRNA vaccine effects on spike protein production and excretion 6:14

Health Minister acknowledges vaccine injuries, including severe neurodegenerative reactions, prompting research funding
  • Increased cancer cases post-pandemic, attributed to various health issues like thrombosis and organ damage 6:31

  • Neurological damage, brain inflammation, and organ damage observed in individuals affected by spike protein and vaccine injuries 7:29

  • Hypersensitivity, autoimmune reactions, and immunodeficiency noted as ongoing issues post-exposure to spike protein and SARS-CoV-2 8:06

  • German Health Minister confirms vaccine injuries and calls for research funding from vaccine companies 9:28

  • Long COVID symptoms persisting in some patients globally, with variations based on genetic makeup and geographic location 11:09

Implications of Spike Protein modifications in mRNA vaccines and its impact on cell entry mechanism
  • Spike protein in mRNA vaccines modified with two Proline substitutions to prevent binding to ACE2 receptor 15:39

  • Question raised on the efficacy of mRNA vaccines in producing functional spike proteins 16:44

  • Modifications hinder the configurational change necessary for virus entry into the cell 16:44

Discussion on spike protein variants, their impact on receptors, and potential long-term health risks
  • Vaccines produce spike protein, not virus, to trigger immune response 17:05

  • Proline substitutions prevent spike protein binding to receptors 18:24

  • Variants evolve to bind to different receptors, causing varied symptoms 20:10

  • New spike protein variants may impact blood-brain barrier and neurotropism 21:09

  • Inhibitors may be needed to block new variant spike protein interactions 21:48

  • Boosters may be necessary to counteract evolving spike protein variants 22:08

Discussion on the origins and characteristics of the novel virus and vaccine development process
  • Developers faced unknown unknowns during vaccine development due to the novel virus 22:29

  • Lack of proactive education about the vaccine and virus in the initial months of the pandemic 23:28

  • Surprise at the virus’s use of multiple entry mechanisms and substitutions in the spike protein 24:29

  • Speculation on the possibility of the virus being man-made due to its sophisticated features 26:15

Discussion on the evolution of viruses, challenges in drug research, and the importance of exploring mucosal vaccines
  • Viruses evolving and changing entry mechanisms pose challenges for drug effectiveness 27:34

  • Clinical trials focusing on bacterial infections and viral reproduction inhibition 27:53

  • Concerns about mutations in the main protease affecting drug efficacy 28:32

  • Comparison of SARS-CoV-2 with other highly dangerous viruses like Epstein-Barr 29:07

  • Lack of continued research on previous viruses like SARS-CoV-1 and potential risks 29:49

  • Importance of exploring mucosal vaccines for better immunity and prevention strategies 30:29

  • Recognition of the need for diversified funding in drug research beyond vaccines 30:51

  • Discussion on the limitations of current vaccine strategies in controlling the pandemic 31:37

  • Advocacy for exploring alternative solutions like mucosal vaccines for better prevention 31:59

Discussion on the impact of spike protein on immune cells and potential long-term health risks
  • Various immune cells are affected by the spike protein, leading to functional deficiencies 32:39

  • Long Covid patients and those with excess spike protein production show imbalances in CD4, CD5, CD3, and CD8 cells 35:39

  • Some individuals may have normal T and B cell counts but experience functional lymphocytopenia 36:19

Discussion on immune deficiencies caused by viral infections, leading to long-term health risks
  • Dual factor of quantitative lymphocytopenia and qualitative immune deficiency 37:52

  • Qualitative immune deficiency can only be diagnosed through functional testing of T cells 38:16

  • Suggested testing of lymphocytes in a Petri dish to assess qualitative damage 38:47

  • Macrophages also qualitatively and quantitatively damaged, impacting immune response 39:40

  • Bacterial infections not combated well due to immune deficiencies, leading to prolonged infections 39:58

  • Rise of fungal infections due to compromised immunity and dysbiosis in the gut biome 40:17

  • Direct infection of bacteria by virus affecting gut biome and leading to overgrowth of pathogenic bacteria 41:21

  • Infection impacting mucosal immunity and ability to prevent virus from entering bloodstream 42:47

Discussion on the impact of Spike protein on mucosal immunity, thrombosis, and endothelium damage
  • Spike protein affects mucosal immunity in the respiratory system, reducing its efficiency 43:08

  • Spike protein suppresses type 1 interferon, making individuals more susceptible to infections 43:30

  • Damage to endothelium by Spike protein leads to thrombosis, not just clotting 46:30

  • Endothelial damage caused by Spike protein increases the risk of thrombosis 47:27

  • Spike protein is detrimental to endothelium and triggers a cascade of thrombosis 47:50

  • The mechanism of clot formation in thrombosis is similar to normal clotting but occurs without external damage 48:11

  • Endothelial cells damaged by Spike protein increase the likelihood of thrombus formation 48:29

Discussion on potential long-term health risks associated with spike protein exposure and endothelial damage
  • Endothelium damage leads to thrombus formation and organ collapse 48:48

  • Spike protein from vaccines can damage endothelium and cause thrombosis 49:05

  • Similarities in health outcomes between COVID and vaccine-related injuries 49:24

  • Not everyone is equally at risk for adverse effects, but specific percentages are unknown 50:21

  • Lack of funding for studies on predisposition to vaccine injuries 50:42

  • Diagnostic tools for post-viral conditions like microthrombi are lacking 51:22

  • Endothelial debris found in blood samples of all patients, indicating widespread damage 52:00

  • Variation in health impact observed in different populations based on factors like immunity and chronic diseases 53:06

  • Developed countries facing more health issues compared to less developed regions 53:29

Impact of underlying inflammation and spike protein on chronic diseases and thrombi formation
  • Population in Africa, India, and Papua New Guinea may have healthier biome due to biodiversity 53:48

  • Underlying inflammation caused by industrial food and lifestyle contributes to chronic diseases 54:08

  • Combination of inflammation and spike protein can lead to severe health complications 54:27

  • Neonates may not be significantly affected by spike protein due to poor immunity 54:45

  • Healthy individuals with balanced diets can also be affected by viral load and comorbidities 55:06

  • Micro thrombi with rubber-like consistency can be difficult to disintegrate 56:27

  • Treatment with certain products can improve micro thrombi and dampen inflammation 57:05

  • Neutrophil elastase fibers result from the combination of spike protein and neutrophils 58:50

Investigating the impact of Spike proteins on health and potential solutions
  • Research on Spike proteins causing insoluble fibers similar to Alzheimer’s amyloid 59:15

  • Hypothesis on how Spike proteins trigger clot formation in inflammatory conditions 59:58

  • Exploration of enzymes to break down fibrils and remove Spike proteins from cells 1:01:18

  • Efforts to develop a common protocol to address health issues caused by Spike proteins 1:03:25

  • Need for more specialized and individualized medicine for complex health conditions 1:04:02

  • Importance of distinguishing the root cause to effectively address health problems 1:04:19

Investigating the root cause of health risks related to spike protein and advancements in treatment
  • Micro thrombi are effects, not causes of health issues 1:04:38

  • Identifying the provocating agent like Sars-Cov-2 is crucial for treatment 1:04:55

  • Progress has been made in understanding and treating the health risks 1:05:16

  • Appreciation for sharing research insights and looking forward to future findings 1:05:35

  • Acknowledgment and gratitude for the audience and researchers 1:07:29